-
Something wrong with this record ?
Chronic inhibition of angiotensin converting enzyme lowers blood pressure in spontaneously hypertensive rats by attenuation of sympathetic tone: The role of enhanced baroreflex sensitivity
M. Behuliak, M. Bencze, A. Boroš, A. Vavřínová, M. Vodička, P. Ergang, I. Vaněčková, J. Zicha
Language English Country France
Document type Journal Article
- MeSH
- Baroreflex * drug effects MeSH
- Hypertension drug therapy physiopathology enzymology MeSH
- Angiotensin-Converting Enzyme Inhibitors * pharmacology MeSH
- Captopril * pharmacology MeSH
- Blood Pressure * drug effects MeSH
- Rats MeSH
- Rats, Inbred SHR MeSH
- Rats, Inbred WKY MeSH
- Heart Rate * drug effects MeSH
- Sympathetic Nervous System * drug effects MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Spontaneously hypertensive rats (SHR) are characterized by sympathetic hyperactivity and insufficient parasympathetic activity, and their high blood pressure (BP) can be lowered by long-term inhibition of the renin-angiotensin system. The aim of our study was to determine the influence of chronic inhibition of angiotensin converting enzyme (ACE) by captopril on cardiovascular regulation by the sympathetic and parasympathetic nervous system. Implanted radiotelemetric probes or arterial cannulas were used to measure mean arterial pressure (MAP), heart rate (HR), and arterial baroreflex in adult SHR and Wistar-Kyoto (WKY) rats under basal or stress conditions. MAP and the low-frequency component of systolic blood pressure variability (LF-SBPV, marker of sympathetic activity) were greater in SHR than in WKY rats. Under basal conditions chronic captopril treatment reduced both parameters more effectively in SHR, and the same was true during acute restraint stress. HR was similar in control rats of both strains, but WKY rats showed greater heart rate variability (HRV), indicating higher parasympathetic activity. Captopril administration increased HR in both strains, whereas HRV was decreased only in WKY. Chronic captopril treatment improved the impaired baroreflex-HR control in SHR by increasing the sensitivity but not the capacity of vagal arm of arterial baroreflex. Captopril treatment attenuated BP changes elicited by dimethylphenylpiperazinium (DMPP, agonist of nicotinic acetylcholine receptors), especially in SHR, indicating that sympathetic nerve transmission is facilitated by angiotensin II more in hypertensive than in normotensive animals. Thus, chronic ACE inhibition improves baroreflex sensitivity and lowers BP through both central and peripheral attenuation of sympathetic tone.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013347
- 003
- CZ-PrNML
- 005
- 20240905133814.0
- 007
- ta
- 008
- 240725e20240528fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biopha.2024.116796 $2 doi
- 035 __
- $a (PubMed)38810397
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Behuliak, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 245 10
- $a Chronic inhibition of angiotensin converting enzyme lowers blood pressure in spontaneously hypertensive rats by attenuation of sympathetic tone: The role of enhanced baroreflex sensitivity / $c M. Behuliak, M. Bencze, A. Boroš, A. Vavřínová, M. Vodička, P. Ergang, I. Vaněčková, J. Zicha
- 520 9_
- $a Spontaneously hypertensive rats (SHR) are characterized by sympathetic hyperactivity and insufficient parasympathetic activity, and their high blood pressure (BP) can be lowered by long-term inhibition of the renin-angiotensin system. The aim of our study was to determine the influence of chronic inhibition of angiotensin converting enzyme (ACE) by captopril on cardiovascular regulation by the sympathetic and parasympathetic nervous system. Implanted radiotelemetric probes or arterial cannulas were used to measure mean arterial pressure (MAP), heart rate (HR), and arterial baroreflex in adult SHR and Wistar-Kyoto (WKY) rats under basal or stress conditions. MAP and the low-frequency component of systolic blood pressure variability (LF-SBPV, marker of sympathetic activity) were greater in SHR than in WKY rats. Under basal conditions chronic captopril treatment reduced both parameters more effectively in SHR, and the same was true during acute restraint stress. HR was similar in control rats of both strains, but WKY rats showed greater heart rate variability (HRV), indicating higher parasympathetic activity. Captopril administration increased HR in both strains, whereas HRV was decreased only in WKY. Chronic captopril treatment improved the impaired baroreflex-HR control in SHR by increasing the sensitivity but not the capacity of vagal arm of arterial baroreflex. Captopril treatment attenuated BP changes elicited by dimethylphenylpiperazinium (DMPP, agonist of nicotinic acetylcholine receptors), especially in SHR, indicating that sympathetic nerve transmission is facilitated by angiotensin II more in hypertensive than in normotensive animals. Thus, chronic ACE inhibition improves baroreflex sensitivity and lowers BP through both central and peripheral attenuation of sympathetic tone.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 12
- $a inhibitory ACE $x farmakologie $7 D000806
- 650 12
- $a baroreflex $x účinky léků $7 D017704
- 650 12
- $a krevní tlak $x účinky léků $7 D001794
- 650 12
- $a kaptopril $x farmakologie $7 D002216
- 650 12
- $a srdeční frekvence $x účinky léků $7 D006339
- 650 _2
- $a hypertenze $x farmakoterapie $x patofyziologie $x enzymologie $7 D006973
- 650 _2
- $a potkani inbrední SHR $7 D011918
- 650 _2
- $a potkani inbrední WKY $7 D011921
- 650 12
- $a sympatický nervový systém $x účinky léků $7 D013564
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bencze, Michal $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Boroš, Almos $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Vavřínová, Anna $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Vodička, Martin $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Ergang, Peter $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Vaněčková, Ivana $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Zicha, Josef $u Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: josef.zicha@fgu.cas.cz
- 773 0_
- $w MED00005486 $t Biomedicine & pharmacotherapy $x 1950-6007 $g Roč. 176 (20240528), s. 116796
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38810397 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133808 $b ABA008
- 999 __
- $a ok $b bmc $g 2143267 $s 1225213
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 176 $c - $d 116796 $e 20240528 $i 1950-6007 $m Biomedicine & pharmacotherapy $n Biomed Pharmacother $x MED00005486
- LZP __
- $a Pubmed-20240725